Trial · NCT07884045
Impact of Ultra-Processed Food Reduction on Remission Duration in Pediatric Crohn's Disease
NCT07884045, Not applicable, Recruiting, University Hospital, Motol
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Impact of Ultra-Processed Food Reduction on Remission Duration in Pediatric Crohn's Disease. Trials, record NCT07884045. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07884045
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Impact of Ultra-Processed Food Reduction on Remission Duration in Pediatric Crohn's Disease
- NCT number
- NCT07884045
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 124 participants, estimated
- Lead sponsor
- University Hospital, Motol
- Conditions
- Crohn Disease (CD)
- Interventions
- Ultra-Processed Food Reduction Counseling, Standard Dietary Counseling
- First posted
- 2026-10-20
- Last updated
- 2026-10-20
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Proportion of Participants Remaining in Clinical Remission at 12 Months | 12 months after randomization | The primary endpoint is the proportion of participants without relapse 12 months after randomization. Relapse is defined as a MINI score ≥8 at any scheduled study visit during the 12-month follow-up (months 3, 6, 9, or 12). Participants who do not meet the relapse criterion are considered to have remained in clinical remission. The primary analysis will follow the intention-to-treat principle. |
| Secondary | Time to Relapse | Up to 12 months after randomization | Time from randomization to the first study visit at which relapse is identified. Relapse is defined as a MINI score ≥8. Participants without relapse will be censored at their last completed study visit. |
| Secondary | Correlation Between Reduction in Ultra-Processed Food Intake and Relapse-Free Remission | Baseline to 12 months | Correlation between the change in ultra-processed food intake, assessed using the Processed Food Questionnaire (PFQ), and relapse-free remission at 12 months. Ultra-processed food intake will be measured using the PFQ, and relapse-free remission will be assessed using the MINI index, with relapse defined as a MINI score ≥8. |
| Secondary | Correlation Between Reduction in Ultra-Processed Food Intake and Time to Relapse | Baseline to 12 months | Correlation between the change in ultra-processed food intake, assessed using the Processed Food Questionnaire (PFQ), and time to first relapse. Ultra-processed food intake will be measured using the PFQ, and time to relapse will be measured in months from baseline to the first occurrence of relapse, defined as a MINI score ≥8. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07884045
GET https://conductscience.org/api/trials/v1/NCT07884045/registered